Published in Med Care on August 01, 2014
Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment Strategies. JAMA Oncol (2016) 1.04
Localized prostate cancer: regional variation and national policy. Med Care (2014) 0.75
Creating a National Provider Identifier (NPI) to Unique Physician Identification Number (UPIN) Crosswalk for Medicare Data. Med Care (2015) 0.75
Implications of evolving delivery system reforms for prostate cancer care. Am J Manag Care (2016) 0.75
Associations Between End-of-Life Cancer Care Patterns and Medicare Expenditures. J Natl Compr Canc Netw (2016) 0.75
Comorbidity measures for use with administrative data. Med Care (1998) 46.67
American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology. J Clin Oncol (2012) 7.16
Physician cost profiling--reliability and risk of misclassification. N Engl J Med (2010) 6.10
Outcomes of localized prostate cancer following conservative management. JAMA (2009) 5.57
The growing burden of chronic disease in America. Public Health Rep (2004) 5.33
A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care (2009) 5.13
Cost implications of the rapid adoption of newer technologies for treating prostate cancer. J Clin Oncol (2011) 4.60
Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst (2008) 4.53
Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity. J Natl Cancer Inst (2012) 3.72
Use of advanced treatment technologies among men at low risk of dying from prostate cancer. JAMA (2013) 3.08
Getting past denial--the high cost of health care in the United States. N Engl J Med (2009) 2.88
Geographic and socioeconomic variation in the treatment of prostate cancer. J Clin Oncol (2005) 2.41
Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate. J Clin Oncol (1995) 2.41
Active surveillance for prostate cancer compared with immediate treatment: an economic analysis. Cancer (2011) 2.36
The lessons of Medicare's prospective payment system show that the bundled payment program faces challenges. Health Aff (Millwood) (2012) 1.88
Utilization and expense of adjuvant cancer therapies following radical prostatectomy. Cancer (2011) 1.85
Measuring efficiency: the association of hospital costs and quality of care. Health Aff (Millwood) (2009) 1.65
Regional variation in total cost per radical prostatectomy in the healthcare cost and utilization project nationwide inpatient sample database. J Urol (2010) 1.64
Understanding variation in primary prostate cancer treatment within the Veterans Health Administration. Urology (2012) 1.62
Geographic variation in Medicare services. N Engl J Med (2013) 1.51
A flexible two-part random effects model for correlated medical costs. J Health Econ (2009) 1.26
Geographic variation in physicians' responses to a reimbursement change. N Engl J Med (2011) 1.18
Overview of methods to estimate the medical costs of cancer. Med Care (2009) 1.16
Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation. Health Technol Assess (2010) 1.13
Geographic variation in fee-for-service medicare beneficiaries' medical costs is largely explained by disease burden. Med Care Res Rev (2013) 1.07
An evaluation of radical prostatectomy at Veterans Affairs Medical Centers: time trends and geographic variation in utilization and outcomes. Med Care (1999) 0.99
Regional, provider, and economic factors associated with the choice of active surveillance in the treatment of men with localized prostate cancer. J Natl Cancer Inst Monogr (2012) 0.97
The cost implications of prostate cancer screening in the Medicare population. Cancer (2013) 0.95
Radiation therapy in non-surgically-treated nonmetastatic prostate cancer: geographic and demographic variation. Urology (2001) 0.88
Geographic variation across veterans affairs medical centers in the treatment of early stage prostate cancer. J Urol (2004) 0.87
Radical prostatectomy: geographic and demographic variation. Urology (2000) 0.86
Geographic variation in Medicare spending. N Engl J Med (2010) 0.83
Effect of practice integration between urologists and radiation oncologists on prostate cancer treatment patterns. J Urol (2013) 0.81
Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell (2007) 30.22
Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA (2003) 16.08
Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA (2004) 14.05
Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation. Nat Biotechnol (2006) 9.95
Are racial and ethnic minorities less willing to participate in health research? PLoS Med (2005) 7.88
Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicity. J Clin Oncol (2014) 6.62
Proteomic analysis of proteins associated with lipid droplets of basal and lipolytically stimulated 3T3-L1 adipocytes. J Biol Chem (2004) 4.89
The need for a public proteomics repository. Nat Biotechnol (2004) 4.60
Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med (2002) 4.45
Sequence and analysis of rice chromosome 4. Nature (2002) 4.39
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol (2011) 4.07
Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity. J Natl Cancer Inst (2012) 3.72
Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog (2005) 3.44
Lactate clearance is a useful biomarker for the prediction of all-cause mortality in critically ill patients: a systematic review and meta-analysis*. Crit Care Med (2014) 3.35
Patterns of use and short-term complications of breast brachytherapy in the national medicare population from 2008-2009. J Clin Oncol (2012) 3.34
Risk factors for femicide in abusive relationships: results from a multisite case control study. Am J Public Health (2003) 3.23
Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J (2003) 3.11
Assessing the impact of a cooperative group trial on breast cancer care in the medicare population. J Clin Oncol (2012) 3.07
Pharmaceutical company payments to physicians: early experiences with disclosure laws in Vermont and Minnesota. JAMA (2007) 3.03
Recruiting vulnerable populations into research: a systematic review of recruitment interventions. J Gen Intern Med (2007) 3.02
Perilipin A mediates the reversible binding of CGI-58 to lipid droplets in 3T3-L1 adipocytes. J Biol Chem (2004) 2.76
Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays. Assay Drug Dev Technol (2004) 2.74
Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst (2006) 2.69
Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet (2004) 2.66
Integrated prostate cancer centers and over-utilization of IMRT: a close look at fee-for-service medicine in radiation oncology. Int J Radiat Oncol Biol Phys (2010) 2.66
Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus. Cell Host Microbe (2010) 2.64
Seminal plasma reduces the effectiveness of topical polyanionic microbicides. J Infect Dis (2007) 2.57
Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation. J Cell Biol (2006) 2.57
Distinct pathways of genomic progression to benign and malignant tumors of the liver. Proc Natl Acad Sci U S A (2007) 2.56
Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors. Eur Urol (2012) 2.52
Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase. J Neurosci (2005) 2.48
Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation (2008) 2.48
The relationship between clinical benefit and receipt of curative therapy for prostate cancer. Arch Intern Med (2012) 2.48
Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol (2007) 2.46
Effect of blinded peer review on abstract acceptance. JAMA (2006) 2.38
The association between diffusion of the surgical robot and radical prostatectomy rates. Med Care (2011) 2.38
Real-time monitoring of morphological changes in living cells by electronic cell sensor arrays: an approach to study G protein-coupled receptors. Anal Chem (2006) 2.32
Sharing of clinical trial data among trialists: a cross sectional survey. BMJ (2012) 2.31
Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40. Hum Mutat (2006) 2.29
Hypofractionated radiation therapy for prostate cancer: risks and potential benefits in a fiscally conservative health care system. Oncology (Williston Park) (2012) 2.29
Patients' views on financial conflicts of interest in cancer research trials. N Engl J Med (2006) 2.29
Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival. J Neurosurg (2012) 2.28
Overall survival advantage with partial nephrectomy: a bias of observational data? Cancer (2013) 2.21
The effect of benign lower urinary tract symptoms on subsequent prostate cancer testing and diagnosis. Eur Urol (2013) 2.19
Purification and characterization of the human gamma-secretase complex. Biochemistry (2004) 2.18
Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer. J Am Coll Cardiol (2012) 2.18
Association between donor and recipient TCF7L2 gene polymorphisms and the risk of new-onset diabetes mellitus after liver transplantation in a Han Chinese population. J Hepatol (2012) 2.17
The importance of clinical trial data sharing: toward more open science. Circ Cardiovasc Qual Outcomes (2012) 2.16
Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty. Urology (2013) 2.16
Temporal trends, practice patterns, and treatment outcomes for infected upper urinary tract stones in the United States. Eur Urol (2012) 2.16
Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists. Med Care (2014) 2.14
Radical prostatectomy vs radiotherapy vs observation among older patients with clinically localized prostate cancer: a comparative effectiveness evaluation. BJU Int (2013) 2.12
The xCELLigence system for real-time and label-free monitoring of cell viability. Methods Mol Biol (2011) 2.10
Identification of mutations in CUL7 in 3-M syndrome. Nat Genet (2005) 2.10
Patient-reported utilization patterns of fentanyl transdermal system and oxycodone hydrochloride controlled-release among patients with chronic nonmalignant pain. J Manag Care Pharm (2003) 2.09
Dynamic monitoring of cytotoxicity on microelectronic sensors. Chem Res Toxicol (2005) 2.08
Early radiotherapy after radical prostatectomy improves cancer-specific survival only in patients with highly aggressive prostate cancer: validation of recently released criteria. Int J Urol (2014) 2.08
A genome-scale resource for in vivo tag-based protein function exploration in C. elegans. Cell (2012) 2.07
Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. Carcinogenesis (2005) 2.05
Salvage external beam radiotherapy for prostate cancer after radical prostatectomy: current status and controversy. Oncology (Williston Park) (2010) 2.01
NCI SEER public-use data: applications and limitations in oncology research. Oncology (Williston Park) (2009) 2.01
Direct and potent regulation of gamma-secretase by its lipid microenvironment. J Biol Chem (2008) 2.00
The relationship of the intensity of posttreatment prostate-specific antigen surveillance and prostate cancer outcomes: results from a population-based cohort. Mayo Clin Proc (2012) 2.00
Incorporation of a hemofilter circuit into venoarterial extracorporeal membrane oxygenation: a novel approach to provide more oxygenation. Intensive Care Med (2015) 1.98
Anesthesiologist involvement in screening colonoscopy: temporal trends and cost implications in the medicare population. Clin Gastroenterol Hepatol (2011) 1.97
A meta-analysis of the association between day-care attendance and childhood acute lymphoblastic leukaemia. Int J Epidemiol (2010) 1.95
Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A. J Hepatol (2008) 1.95
Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study. Arch Ophthalmol (2007) 1.94
Delays in diagnosis and bladder cancer mortality. Cancer (2010) 1.92
Class prediction models of thrombocytosis using genetic biomarkers. Blood (2009) 1.92
Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease. FASEB J (2005) 1.90
Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice. Proc Natl Acad Sci U S A (2005) 1.90
Traditional Chinese medication Tongxinluo dose-dependently enhances stability of vulnerable plaques: a comparison with a high-dose simvastatin therapy. Am J Physiol Heart Circ Physiol (2009) 1.90
CUL7: A DOC domain-containing cullin selectively binds Skp1.Fbx29 to form an SCF-like complex. Proc Natl Acad Sci U S A (2002) 1.89
The relationship between alcohol use and cigarette smoking in a sample of undergraduate college students. Addict Behav (2006) 1.89
Mobile genetic element-encoded cytolysin connects virulence to methicillin resistance in MRSA. PLoS Pathog (2009) 1.89
The Bacillus subtilis spore coat protein interaction network. Mol Microbiol (2006) 1.88
Use of hospital-based acute care among patients recently discharged from the hospital. JAMA (2013) 1.88
Phospholipase dalpha1 and phosphatidic acid regulate NADPH oxidase activity and production of reactive oxygen species in ABA-mediated stomatal closure in Arabidopsis. Plant Cell (2009) 1.88
Practice-setting and surgeon characteristics heavily influence the decision to perform partial nephrectomy among American Urologic Association surgeons. BJU Int (2012) 1.87
Vascular development of the brain requires beta8 integrin expression in the neuroepithelium. J Neurosci (2005) 1.85
Physician violations of online professionalism and disciplinary actions: a national survey of state medical boards. JAMA (2012) 1.81
Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. Infect Immun (2011) 1.79
Senescence-associated exosome release from human prostate cancer cells. Cancer Res (2008) 1.78
Childbirth and pelvic floor dysfunction: an epidemiologic approach to the assessment of prevention opportunities at delivery. Am J Obstet Gynecol (2006) 1.77
Tests and expenditures in the initial evaluation of peripheral neuropathy. Arch Intern Med (2012) 1.75
Does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis. J Urol (2012) 1.75